185 related articles for article (PubMed ID: 37007076)
21. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
22. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.
Murphy AJ; Axt JR; de Caestecker C; Pierce J; Correa H; Seeley EH; Caprioli RM; Newton MW; de Caestecker MP; Lovvorn HN
Int J Cancer; 2012 Sep; 131(6):E983-94. PubMed ID: 22437966
[TBL] [Abstract][Full Text] [Related]
24. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.
Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA
Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352
[TBL] [Abstract][Full Text] [Related]
25. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
[TBL] [Abstract][Full Text] [Related]
26. Proliferation and maturation indices in nephrogenic rests and Wilms tumor; the emergence of heterogeneity from dormant nodular renal blastema.
Bove KE; Lewis C; Debrosse BK
Pediatr Pathol Lab Med; 1995; 15(2):223-44. PubMed ID: 8597811
[TBL] [Abstract][Full Text] [Related]
27. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
Dekel B; Metsuyanim S; Schmidt-Ott KM; Fridman E; Jacob-Hirsch J; Simon A; Pinthus J; Mor Y; Barasch J; Amariglio N; Reisner Y; Kaminski N; Rechavi G
Cancer Res; 2006 Jun; 66(12):6040-9. PubMed ID: 16778176
[TBL] [Abstract][Full Text] [Related]
28. The prognosis of prechemotherapy blastemal predominant histology subtype in Wilms tumor: A retrospective study in China.
Huang J; Zhang Y; Zhen Z; Lu S; Zhu J; Wang J; Sun F; Liu Z; Gao Y; Li H; Zhang Y; Sun X
Pediatr Blood Cancer; 2020 Nov; 67(11):e28567. PubMed ID: 32813315
[TBL] [Abstract][Full Text] [Related]
29. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
[TBL] [Abstract][Full Text] [Related]
30. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
[TBL] [Abstract][Full Text] [Related]
31. Conserved and Divergent Features of Mesenchymal Progenitor Cell Types within the Cortical Nephrogenic Niche of the Human and Mouse Kidney.
Lindström NO; Guo J; Kim AD; Tran T; Guo Q; De Sena Brandine G; Ransick A; Parvez RK; Thornton ME; Baskin L; Grubbs B; McMahon JA; Smith AD; McMahon AP
J Am Soc Nephrol; 2018 Mar; 29(3):806-824. PubMed ID: 29449449
[TBL] [Abstract][Full Text] [Related]
32. The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour.
Fukuzawa R; Anaka MR; Morison IM; Reeve AE
PLoS One; 2017; 12(10):e0186333. PubMed ID: 29040332
[TBL] [Abstract][Full Text] [Related]
33. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
34. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
35. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
[TBL] [Abstract][Full Text] [Related]
36. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
[TBL] [Abstract][Full Text] [Related]
37. Multidisciplinary approach to wilms' tumor: a retrospective analytical study of 53 patients.
Naguib SF; El Haddad A; El Badawy SA; Zaghloul AS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):410-23. PubMed ID: 20571600
[TBL] [Abstract][Full Text] [Related]
38. A multi-Gaussian model for apparent diffusion coefficient histogram analysis of Wilms' tumour subtype and response to chemotherapy.
Hales PW; Olsen ØE; Sebire NJ; Pritchard-Jones K; Clark CA
NMR Biomed; 2015 Aug; 28(8):948-57. PubMed ID: 26058670
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to desmin identify the blastemal component of nephroblastoma.
Folpe AL; Patterson K; Gown AM
Mod Pathol; 1997 Sep; 10(9):895-900. PubMed ID: 9310952
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
